SG
OKUR

StepStone Group’s OnKure Therapeutics OKUR Stock Holding History

StepStone Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
2,660,612
+2,168,674
+441% +$6.7M 5.31% 4
2025
Q4 		$1.35M Hold
491,938
– – 0.72% 14
2025
Q3 		$1.35M Hold
491,938
– – 0.64% 11
2025
Q2 		$1.18M Hold
491,938
– – 2.33% 9
2025
Q1 		$2.12M Hold
491,938
– – 2.17% 8
2024
Q4 		$4.23M Buy
+491,938
New +$7.45M 3.7% 5

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

StepStone Group's OKUR Position: Q1 2026 in Review

StepStone Group increased its OnKure Therapeutics (OKUR) stake by 441% in Q1 2026, buying an estimated $6.7M and bringing the position to 2,660,612 shares worth $11M. The position accounts for 5.31% of the portfolio, ranked #4.

StepStone Group first reported a position in OKUR in Q4 2024 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • StepStone Group held 2,660,612 shares of OnKure Therapeutics worth $11M as of Q1 2026.
  • StepStone Group bought 2,168,674 OnKure Therapeutics shares in Q1 2026, an estimated $6.7M.
  • OnKure Therapeutics made up 5.31% of StepStone Group's portfolio in Q1 2026, its #4 holding.
  • StepStone Group first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on StepStone Group's 13F filing for Q1 2026, filed 15 May 2026.